5-Year Impact Factor: 0.9
Volume 34, 12 Issues, 2024
  Letter to the Editor     July 2024  

Prevalence of Anxiety and Depression among Healthcare Workers During the Omicron Pandemic and Its Impact on Gastrointestinal Symptoms

By Xiaoqiang Liu, Chanchan Lin, Yilin Zeng, Peizhong Chen, Yisen Huang

Affiliations

  1. Department of Gastroenterology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Fujian, China
doi: 10.29271/jcpsp.2024.07.858

Sir,

The COVID-19 pandemic, particularly during its Omicron phase, challenged the healthcare systems worldwide and placed unprecedented stress on healthcare workers.1 This stress manifested not only in an increased psychological burden but also in physical symptoms, particularly gastrointestinal complaints, which may have reflected the profound impact of sustained high stress, and anxiety levels.2 In response to this crisis, a detailed cross-sectional study was conducted at Quanzhou's First Hospital. A total of 360 healthcare workers, including doctors, nurses, and administrative staff, were assessed for mental health disorders and gastrointestinal symptoms during the height of the Omicron pandemic. The generalised anxiety disorder-7 (GAD-7) with scores ≥5 indicating anxiety;3 the patient health questionnaire-9 (PHQ-9) with scores ≥5 suggesting depression;4 and the insomnia severity index (ISI) with scores ≥8 indicating insomnia, were utilised alongside a gastrointestinal symptom questionnaire.5 This questionnaire rated symptoms such as abdominal pain, diarrhoea, bloating, and nausea on a scale from 0 (no symptoms) to 4 (symptoms more than four times per week), generating a total gastrointestinal symptom score (TGSS) by summing these individual scores. All analyses were performed using R statistical software (version 4.2.2, http:// www.R-project.org, The R Foundation) and free statistics analysis platform (version 1.8, Beijing, China).

The findings revealed high prevalence rates of mental health disorders, with 51.9% of participants reporting anxiety, 45.8% depression, and 41.7% experiencing insomnia. Doctors exhibited the highest rate of insomnia at 50.3% (Table I). The logistic regression analysis was adjusted for a comprehensive set of covariates: Age, gender, marital status, education level, underlying health conditions, profession, and the risk level of the work area. This adjustment was crucial to isolate the effects of gastrointestinal symptoms on mental health from other potential confounders. The analysis showed that a higher total gastrointestinal symptom score (TGSS) was significantly associated with an increased likelihood of both anxiety (OR = 1.23, 95% CI: 1.10 - 1.38, p <0.001) and depression (OR = 1.46, 95% CI: 1.26 - 1.70, p <0.001).

Table I: The basic characteristics of the participating healthcare workers.
 

Variables

Total
(n = 360)

Doctors
(n = 151)

Nurses

(n = 184)

Administrative staff (n = 25)

p-value

Statistics

Gender, n (%)

- - - -

<0.001

98.076

     Male

86 (23.9)

69 (45.7)

4 (2.2)

13 (52)

-

-

     Female

274 (76.1)

82 (54.3)

180 (97.8)

12 (48)

-

-

Age, n (%)

- - - -

0.53

Fisher

     20-29 year

107 (29.7)

43 (28.5)

53 (28.8)

11 (44)

-

-

     30-39 year

178 (49.4)

71 (47)

95 (51.6)

12 (48)

-

-

     40-49 year

57 (15.8)

29 (19.2)

26 (14.1)

2 (8)

-

-

     50-59 year

18 ( 5.0)

8 (5.3)

10 (5.4)

0 (0)

-

-

Marriage, n (%)

- - - -

0.117

4.299

     Single

107 (29.7)

43 (28.5)

52 (28.3)

12 (48)

-

-

     Married

253 (70.3)

108 (71.5)

132 (71.7)

13 (52)

-

-

Education, n (%)

- - - -

<0.001

Fisher

     Associate’s degree

109 (30.3)

2 (1.3)

97 (52.7)

10 (40)

-

-

     Bachelor’s degree

154 (42.8)

56 (37.1)

87 (47.3)

11 (44)

-

-

     Master’s degree

93 (25.8)

89 (58.9)

0 (0)

4 (16)

-

-

     Ph.D.

4 ( 1.1)

4 (2.6)

0 (0)

0 (0)

-

-

Underlying conditions, n (%)

- - - -

0.478

Fisher

     Yes

14 ( 3.9)

8 (5.3)

6 (3.3)

0 (0)

-

-

     No

346 (96.1)

143 (94.7)

178 (96.7)

25 (100)

-

-

Risk level of the work area, n (%)

- - - -

<0.001

24.211

     Low risk

117 (32.5)

67 (44.4)

38 (20.7)

12 (48)

-

-

     High risk

243 (67.5)

84 (55.6)

146 (79.3)

13 (52)

-

-

Insomnia, n (%)

- - - -

0.004

11.25

     Yes

150 (41.7)

76 (50.3)

61 (33.2)

13 (52)

-

-

     No

210 (58.3)

75 (49.7)

123 (66.8)

12 (48)

-

-

Anxiety, n (%)

- - - -

0.704

0.701

     Yes

187 (51.9)

80 (53)

96 (52.2)

11 (44)

-

-

     No

173 (48.1)

71 (47)

88 (47.8)

14 (56)

-

-

Depression, n (%)

- - - -

0.2

3.216

     Yes

165 (45.8)

77 (51)

79 (42.9)

9 (36)

-

-

     No

195 (54.2)

74 (49)

105 (57.1)

16 (64)

-

-

ISI score, Median (IQR)

9.0 (5.0, 14.0)

7.0 (4.0, 11.0)

11.0 (5.0, 15.0)

7.0 (4.0, 14.0)

0.001

13.667

GDA-7 score, Median (IQR)

4.0 (1.0, 7.0)

4.0 (1.0, 7.0)

4.0 (1.0, 7.0)

5.0 (3.0, 7.0)

0.364

2.019

PHQ-9 score, Median (IQR)

5.0 (2.0, 9.0)

4.0 (2.0, 8.0)

6.0 (2.0, 9.0)

5.0 (3.0, 8.0)

0.102

4.572

TGSS, Median (IQR)

1.0 (0.0, 3.0)

1.0 (0.0, 3.0)

1.0 (0.0, 4.0)

0.0 (0.0, 2.0)

0.422

1.727

Ph.D., Doctor of Philosophy; GAD-7, Generalised anxiety disorder-7; PHQ-9, Patient health questionnaire-9; ISI, Insomnia severity index; TGSS, Total gastrointestinal symptom score.

These results underscore the strong correlation between increased gastrointestinal symptoms and the likelihood of experiencing mental health disorders among the healthcare workers. The study’s findings advocate for an integrated approach to healthcare that simultaneously addresses mental health and gastrointestinal issues, potentially improving the overall well-being and effectiveness of healthcare professionals working under the pandemic-induced stress.

COMPETING INTEREST:
The authors declared no conflict of interest.

AUTHORS’ CONTRIBUTION:
XL, CL: Research design and data collection.
YZ: Technical support and data collection.
PC: Specialised knowledge, literature, revision, and comprehensive analysis of the research.
YH: Supervision and guidance of the research.
All authors approved the final version of the manuscript to be published.

REFERENCES

  1. Wang C, Horby PW, Hayden FG, Gao GF. A novel corona- virus outbreak of global health concern. Lancet 2020; 395 (10223):470-3. doi: 10.1016/S0140-6736(20)30185-9.
  2. Kang L, Ma S, Chen M, Yang J, Wang Y, Li R, et al. Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: A cross-sectional study. Brain Behav Immun 2020; 87:11-7. doi: 10.1016/j.bbi.2020.03. 028.
  3. Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: A systematic review and diagnostic meta-analysis. Gen Hosp Psychiatry 2016; 39:24-31. doi: 10.1016/j.genhosppsych.2015.11.005.
  4. Glazer K, Rootes-Murdy K, Van Wert M, Mondimore F, Zandi P. The utility of PHQ-9 and CGI-S in measurement-based care for predicting suicidal ideation and behaviors. J Affect Disord 2020; 266:766-71. doi: 10.1016/j.jad.2018.05.054.
  5. Bastien CH, Vallieres A, Morin CM. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2001; 2(4):297-307. doi: 10. 1016/s1389-9457(00)00065-4.